Inoltre, siamo grati alla Sig.na Monica Bretta per il suo prezioso lavoro di
dattilografia.
BIBLIOGRAFIA
1) Agnati LT., K.,Locatelli V., Benfanti F., Zini I., Panerai AE., El Eltreby M.F., Hökfelt T.
(1982): Neuroanatomical methods for the quantitative evaluation of coexistence of
trasmit-ters in nerve cells. Analysis of the ACTH and B-Endorphin immunoreactive nerve cell
bo-dies of the mediobasal hypothalamus of the rat. i. Neurosci Methods 5:203-214
2) Aronin N., Liutta A.S., Shickmanter B., Schussler G.C., Krieger D.T. (1981): Impaired
clearance of B-Lipotropin in uremia. J. Clin. Endocrinol. 53:797-801.
3) Bagnoli F., Facchinetti F., Buonocore G., Petraglia E., Parrini D., Genazzani AR. (1982):
Comportamento dei livelli plasmatici di ACTH,B-EP e cortisolo in relazione allo stress della
nascita Riv. Ital. Ped. 8:47-51.
4) Bloom F., Battenberg E., Kossier J., Ling N., Gulleman R. (1978): Neurons containing
B-Endorphin in rat brain exist separately from those containing enkephalin:
immunocyto-chemical studies. Proc. nan. Acad. Sci. USA 75:1591-1595.
5) Brambilla E., Genazzani AR., Facchinetti F., Parrini D., Petraglia E., Sacchetti E. Scarone 5.,
Guastalla A., D'Antona N. (1981): B-Endorphin and B-Lipotropin plasma levels in chronic
schizofrenia. prirnary affective disorders and secondary affective disorders.
Psychoneu-roendocrinology 6:32 1-330.
6) Burbach J.P.H., De Kloet FR., Loeber J.G., Verhoef i., Wiegant V.M., De Wied D. (1980):
Sele-ctive conversion of B-Endorphin 1010 peptides related to gamma and alfa-endorphin.
Na-ture (Lond.) 238:96-97.
7) Cavagnini F., Facchinetti F., Invitti C., Danesi L., Petraglia F., Parrini D., Fracchia 5.,
Genaz-zani AR. (1983): BasaI and Metyrapone-stimulate AcTH. B-Lipotropin and B-Endorphin
se-cretion in obese patients. in “Neuropeptides and Psychomatic processes’ (Endroczi et al.
eda) Akadémial Kiado, Budapest, pp 561-567
8) Chaukin C., James LE., Goldatein A. (1982): Dynorphin is a specific endogenous ligand of
the opioid receptor. Science 215:413-415.
9) Cleeland CS.. Shacham 5., Dahl J.L., Orrison W. (1984) B-Endorphin and the severity of
pain. Neurology 34:378-380
10) Clement-Jones V., Lowry PI., Ress L.H., Besser CM. (1980): Development of a specific
extra-cted radioimmunoassay for methiodine enkeohalin in human plasma and cerebrospinal
fluid. J. Endocrinol. 86:231-243.
11) Comb M., Seeburg P.H., Adelman J.,Eideni.,Herbert E. (1982): Primary structure of the
hu-man Met- and Leu-Enkephalin precursor and its mRNA. Nature 295:663-666.
12) Facchinetti E.,Volpe A.,Nappi G.,Petraglia F.,Genazzani A.R. (1985): Impairment of
adrener-gic indiced propiomelanancortin-related peptide release in heroin addict. Acta
Endocrinolo-gica 108:1-5.
13) Facchinetti F.,Petraglia F.,Nappi G.,Martignoni E.,Antoni G.,Partini D.,GenazzaniA.R.
(1983): Different patterns of central end periphetral B-EP, B-LPH and ACTH throughout
life. Peptides 6:469-474.
14) Facchinetti F., Centini G., Parrini D., Petraglia F., D’Antona N., Cosmi E.V. Genazzani A.R.
(1982): Opioid plasma levels a during laboor. Gynecol. Obstet. Invest. 13:155-163.
15) Facchinetti F., Gasso A., Perraglia F., Parrini D., Volpe A., Genazzani A.R. (1984): Impaired
circadian rhytmicity of B-Lipotrophin, B-Endorphin and ACTH in heroin addicts. Acta
Endocrinologica 105:149-155.
16) Facchinetti F.. Nappi G.. Savoldi E., Genazzani A.R. (1981): Primary headches: reduced
circulating B-Lipotropin and B-Endophin levels with impaired reactivity to acupunture.
Chephalgia I: 195-201.
17) Facchinetti F., Perraglia F., Sandrini G.,Alfonsi E., Nappi G.,Genazzani AR. (1984):
Conco-mitant increase in nociceptive flexion reflex thresold and plasma opiods following
tran-scutaneos nerve stimulation. Pain 19:295-3<13.
18) Facchinetti E.. Nappi G.. Petraglia E., Marrignoni E.. Sintoriani E., Genazzani AR. (1984):
Central ACTH deficit in degenerative and vascular dementia. Life Sci. 35 1691-1627.
19) Facchinetti E.. Bagnoli E., Perraglia F., Parrini D., Sardelli S., Genazzani A.R. (1983):
Fetomaternal opioid levels and partourition. Obstet. Gynecol. 62:764-768.
19a)Facchinetti E., Bagnoli F., Bracci R. and Genazzani AR. (1982): Plasma Opioids in the first
hours of life. Red. Res. 16: 95-97
20) Gautray J.P., Jolivet A.. Vielh J.P. (1977): Presence of immunoassayable B-Endorphin in
hu-man amniotic fluid: elevation in cases of fetal distress. Am. i. Obstet Gynecol, 126:211-213.
21) Genazzani AR., Petraglia F.. Facchinetti E., Volpe A.. Giarrè G., Santi M., Baraldi M.:
Opioids and pregnancy in “Opiod modulalion of endocrine function”. Ed. by G. Delitala et
al., Raven Press.: 237-246 (1984).
22) Genazzani AR., Facchinetti E., Ricci-Danero M. G., Parrini D., Petraglia F.. La Rosa R.,
D’Antona N. (1981b): Beta-Lipotropin and Beta-Endorphin in physiological and surgical
menopause. J. Endocrinol. Invest. 4:375-378.
23) Genazzani AR., Perraglia F., Facchinetti F.. Storchi R., Campanini D. De Leo V.. La Marca S.,
Volpe A. (1984): Opioids and mestrual cyclicity. Elsevier Biomedical Press, Amsterdam: 87-92.
24) Genazzani A.R., Petraglia E., Facchinetti E., Facchini V., Volpe A., Alessandrini C.: (1984):
Increase of proopiomelanocortin-related peptides during subjective menopausal flushes.
Am. J. Obstet. Gynecol. 149:775-779.
25) Genazzani AR., Facchinetti E., Parrini D. (1981 a): Beta-Lipotropin and Beta-Endorphin
plasma levels during pregnancy. Clin. Endocrinol. 14:409-416.
26) Genazzani A.R.. Nappi G., Facchinetti F., Micieli G., Petraglia E., Bono G., Monittola C..
Savoldi F. (1984): Progressive impairment of CSF B-EP levels in migraine sufferers. Pain 18:
127-133
27) Genazzani A. R., Facchinetti E., Pintor C., Puggioni R.. Parrini D., Petraglia E., Bagnoli E.,
Corda R. (1983): Proopiomelanocortin-related peptides plasma levels throughout
pre-puberty and pre-puberty. I. Clin. Endocrinol. Metab. 57:56-61
27a)Genazzani A. R., Petraglia E., Nappi G., Martignoni E., De Leo M.. Volpe A.. Facchinetti E.
(1984): Lack of correlation between amniotic fluid and maternal> plasma contents of
B-Lipotropin and ACTH in normal and pathological pregnancies. Am. J. Obstet. Ginecol. 148:
198-203.
28) Gerner R.H., Sharp B. and Catlin G.H. (1982): Peripherally administered B-Endorphin
in-creases cerebrospinal fluid endorphin i im immunoreactivity. J. Clin. Endocrinol. Metab.
55:358-360.
29) Ginzler AR. (1981>): Endorphin-mediated increases in pain threshold during pregnancy.
Nature 210:193-195.
30) Givens J. R.. Wied,erman E.. Andersen R. N.. Kitabchi AL. (198>>): Endorphin and
B-Lipotropin plasma levels in hirsute women: correlation with weight. i. J. Clin.
Endocrinol>. Metab. 51>:957-976.
31) Goldstein A.. Tachibana 5.. Lowney L.1.. l-Hunkapiller M.. Hood L. (1979): I)Dynorphin
(1-13), an exraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. USA 76: 6666-667”.
32) Gramsch C., Hollt V., Meharaein P., A.. Herz A. (1918): Regional distribution of
methionine-enkephanin and beta~endorphin-like immunoreactivity in human brain and pituitary.
Brain Rcs. 171:261-27(1.
33) Hughes J. Smith T.W., Kosterliz H.W.. Fothergill 1.. A., Morgan B. A. and Morris H.R.
(1975) ldentification of two related pentapeptides from brain poten opiate agonist activity.
Nature 258:577-579
34) Li C.l I. Barnafi L., Chrelien M., Chung C. (1966): Isolation and aminoacid sequence of
beta-LPH from sheep pituitary glands. Nature 208:1039-11>94.
35 Mathews IM., Foelich C.J., Sibbit W.L., Bantkhurst A.D. (1983): Enhancement of natural
cytotoxicity by B-Endorphin J. of lmmunoology 130:1658-1662.
36) Mains R.B.. Fipper B.. Ling N. (1977): Common precursor to corticotropin and endorphin.
Proc. Natl. Acad. Sci. USA 74:3”14-3”18.
37) Morley J.E. (1981): The endocrinology of the opiates peptides. Metabolism 30:195-196.
38) Nakai Y ., Nakao K.. Oki S. Imura H. (1978): Presence of immunoreactive B-EP in plasma of
patients with Nelson’s and Addisons discease. Life Sci. 23:2239- 2298.
39) Nakai Y.. Nakao K.. Oki S., Imura H. (1978): Presence of immunoreactive LPH and EP in
human placenta. Lite Sci 23-2013-2018.
40) Nakao K., Nakai Y., Oki S., Matsubara S., Honishi T. Nishitani H. and Imura H. (1980):
Im-munoreactive B-endorphin in human cerebrospinal fluid. J. Clin. Endocrinol. Metab.
50:230-235.
41) Nakao K., Nakai y , Oki S.. Horii K.. Imura H. (1978): Presence of immunoractive
B-En-dorphin in normal human plasma. A concomitant release of B-EnB-En-dorphin with
arenocorti-cotropin after metyrapone administration. J. Clin. Invest. 62:1395-1402.
42) Nappi G., Petraglia F., Murtignoni E., Facchinetti F., Bono G.. Genazzani AR. (1985) B-EP
cerebrospinal fluid decrease in untreated parkinsonian patients Neurology, in stampa.
43) Nappi G.. Facchinetti F.. Legante G., Parrini D., PetragliA E., Savoldi F., Genazzani AR.
(1982): Different releasing effects of traditional manual acupunture and electro-acupunture
on proopio-melanocortin-related peptides Acupunt. Elec. Therap. Res. Int. J. 7:93-103.
44) Uliver C.. Mical R.S. and Porter J.C. (1977): Hypothalamic-pituitary vasculature: evidence
for retrograde blood flow pituitary. Endocrinology 101:598-604.
45) Panerai A.E.,Martini A.. Di Giulio A.M., Fraioli F., Vegni C. Pardi G.. Marini A.and
Man-tegazza P. (1983): Plasma B-Endorphin, B-Lipotropin and Met-Enkephalin concentrations
during pregnancy in normal and drug-addicted women and their newborn. J. Clin.
Endocri-nol. Metab. 57:537-543.
46) Petraglia lv, Facchinetti F.. Parrini D.. Micieli G.. De Luca S., Genazzani AR. (1983):
Simul-taneous circadian variations of plasma ACTH,B-LPH and Cortisol. Horm. Res. 17:147-152.
47 Petraglia F., Facchinetti E., Martignoni E., Nappi G., Volpe A.. Genazzani AR. (1984):
Sero-toninergic agonist increase plasma levels of B-Endorphin and B-Lipotropin in humans. J.
Clin. Endocrinol. Metab. 59:1138-1 142.
48) Petraglia F., Penalva A., Genazzani AR., Muller FE. (1982): Stimulation of B-EP and B-LPH
release from anterior but not the neurointermediate pituitary lobe in the rat after
administr-ation of serotonin acting drugs. Life Sci. 31:2809-2817.
49) Petraglia E., Baraldi M.. Giarrè G.. Facchinetti F.. Santi M., Volpe A., Genazzani AR. (1985):
Opioid peptides of the pituitary and hypothalmus: changes in pregnant and Iactating rats. J.
Endocrinol. 105: 239-245.
49a)Petraglia F., Penalva A., Locatelli V., Cocchi D., Panerai A.F.. Genazzani AR. and Muller
E.E. (1982): Effects of gonadectomy and gonadal steroid replacement on pituiìary and
plasma endorphin levels in the rat. Endocrinologv 11:1224-1229.
50) Reid R.L., Yen S.SC. (1981): B-Endorphin stimulates the secretion of insulin and glucagon in
humans. J. Clin. Endocrinol. Melab. 52:594-599.
51) Rider S.W., Eng J. (1981): Radioimmunoassay of leucine-enkephalin like sibstance in human
and canine plasma. J. Clin. Endocrinol. Metab. 52:367-369.
52) Risch S.C., Cohen R.M., Janowsky D.S., Kalin N.H., Murphy D.L.. (1980): Mood and
beha-vioral effect of physostigmine on human are accomapined by elevation in plasma
B-Endor-phin and Cnrtisol. Science 207:1545-1546.
53) Rossier J. (1982): Opioid peptides have found their roots. Nature 298:221-222.
54) Salar G., Mingrino S., Bosio A., Trabucchi M. (1981): Effects of transcutaneus electrotherapy
on CSF B-Endorphin content in patients without pain problems. Pain 10: 169-172.
55) Salerno E., Martini A.. Bruno S.. Santambrogio R., Mantegazza I., Panerai AE. (1984):
Endorphins in liver desease. Central and Peripheral endorphins. Ed. LE. Muller and AR.
Genazzani: 259-264.
56) Schlachter L.B., Wardlaw S.L., Tindall G.T. and Frantz A.G. (1983): Persistence of
B-endorphin in human cerebrospinal fluid after hypophisectomy. J. Clin. Endocrinol. Metab.
57; 221-224
57) Wingstrand KG. (1966): Microscopic anatomy, nerve supply and blood supplv of the pars
intermedia. In: The pituitary gland Harris and Donovan (ED) pp. 1-27 Butterworths,
London.
58) Worstman J., Wehrenbcrg W., Gavin III J.R.. Allen J.P.. (1984): Eevated levels of plasma
B-Endorphin and gamma-3-melanocyte stimulating hormone in the polycystic ovary
syndrome. Obstet. Gynecol. 630-634.
Nel documento
La β -Endorfina plasmatica e
(pagine 38-43)